Additionally, it is recommended for individuals who are dealing with weight-related medical conditions like high blood pressure, type 2 diabetes, or high cholesterol
Moreover, excess weight can strain joints, leading to conditions such as osteoarthritis and exacerbating respiratory issues including obstructive sleep apnea
Key Takeaways Oral GLP-1 receptor agonists are now the primary areas of innovation with the promise of giving patients a more practical alternative to injectable obesity therapies and, hopefully, higher rates of long-term adherence growing from $1.95 billion revenue in 2025 to account for more than 48% of the market by 2035
Total antioxidant status, total oxidant status, and related indices were measured
No decrease in any of the oxidative stress markers was found in the control group